H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.
Literal federal measure citations: H.Res.1090
2026 · 3rd Quarter (July 1 - Sep 30)
ASTELLAS PHARMA US, INC
Filed by THEGROUP DC, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $70,000.00
- Expenses
- Not reported
- Registrant
- THEGROUP DC, LLC
- Client
- ASTELLAS PHARMA US, INC
- Filing UUID
- a5e9b2b4-d1d7-488d-9a27-3c75ac14aa81
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.
Literal federal measure citations: H.Res.1090
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.